187 related articles for article (PubMed ID: 9121184)
21. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
[TBL] [Abstract][Full Text] [Related]
22. [Malignant melanomas in pregnancy].
Landthaler M; Braun-Falco O
Dtsch Med Wochenschr; 1985 Aug; 110(35):1319-23. PubMed ID: 4028985
[TBL] [Abstract][Full Text] [Related]
23. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
24. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
Kruper LL; Spitz FR; Czerniecki BJ; Fraker DL; Blackwood-Chirchir A; Ming ME; Elder DE; Elenitsas R; Guerry D; Gimotty PA
Cancer; 2006 Nov; 107(10):2436-45. PubMed ID: 17058288
[TBL] [Abstract][Full Text] [Related]
25. Noncutaneous melanoma have distinct features from each other and cutaneous melanoma.
Tas F; Keskin S; Karadeniz A; Dağoğlu N; Sen F; Kilic L; Yildiz I
Oncology; 2011; 81(5-6):353-8. PubMed ID: 22248874
[TBL] [Abstract][Full Text] [Related]
26. DNA level, tumor thickness, and stereological estimates of nuclear volume in stage I cutaneous malignant melanomas. A comparative study with analysis of prognostic impact.
Sørensen FB; Kristensen IB; Grymer F; Jakobsen A
Am J Dermatopathol; 1991 Feb; 13(1):11-9. PubMed ID: 2003643
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous malignant melanoma. II. The natural history and prognostic factors influencing the development of stage II disease.
Berdeaux DH; Meyskens FL; Parks B; Tong T; Loescher L; Moon TE
Cancer; 1989 Apr; 63(7):1430-6. PubMed ID: 2920369
[TBL] [Abstract][Full Text] [Related]
28. DNA ploidy in malignant melanoma, skin cancer and pigmented nevi.
Skowronek J; Adamska K; Filipiak K; Karaś Z; Krenz RM; Rutkowski R; Warchoł JB
Neoplasma; 1997; 44(5):282-8. PubMed ID: 9473786
[TBL] [Abstract][Full Text] [Related]
29. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma.
Kheir SM; Bines SD; Vonroenn JH; Soong SJ; Urist MM; Coon JS
Ann Surg; 1988 Apr; 207(4):455-61. PubMed ID: 3355269
[TBL] [Abstract][Full Text] [Related]
31. Independent prognostic importance of vascular invasion in nodular melanomas.
Straume O; Akslen LA
Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
[TBL] [Abstract][Full Text] [Related]
32. P90 exceeding rate as a prognostic factor in primary malignant melanoma of the skin. A DNA image cytometric study.
Talve LA; Collan YU; Ekfors TO
Anal Quant Cytol Histol; 1997 Oct; 19(5):393-403. PubMed ID: 9349899
[TBL] [Abstract][Full Text] [Related]
33. The female superiority in survival in clinical stage II cutaneous malignant melanoma.
Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
Cancer; 1982 May; 49(9):1941-4. PubMed ID: 7074591
[TBL] [Abstract][Full Text] [Related]
34. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
[TBL] [Abstract][Full Text] [Related]
35. Mucosal melanomas.
Tomicic J; Wanebo HJ
Surg Clin North Am; 2003 Apr; 83(2):237-52. PubMed ID: 12744608
[TBL] [Abstract][Full Text] [Related]
36. Metastatic disease in patients with newly diagnosed malignant melanoma.
Zartman GM; Thomas MR; Robinson WA
J Surg Oncol; 1987 Jul; 35(3):163-4. PubMed ID: 3599990
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
[TBL] [Abstract][Full Text] [Related]
38. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
Gimotty PA; Elder DE; Fraker DL; Botbyl J; Sellers K; Elenitsas R; Ming ME; Schuchter L; Spitz FR; Czerniecki BJ; Guerry D
J Clin Oncol; 2007 Mar; 25(9):1129-34. PubMed ID: 17369575
[TBL] [Abstract][Full Text] [Related]
39. Sentinel lymph node status is the most important prognostic factor in patients with melanoma of the scalp.
Cappello ZJ; Augenstein AC; Potts KL; McMasters KM; Bumpous JM
Laryngoscope; 2013 Jun; 123(6):1411-5. PubMed ID: 23625541
[TBL] [Abstract][Full Text] [Related]
40. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
von Roenn JH; Kheir SM; Wolter JM; Coon JS
Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
